RuPhos Pd G3
CAS: 1445085-77-7
Ref. 3D-FR137452
1g | 346,00 € | ||
2g | 542,00 € | ||
5g | 1.135,00 € | ||
250mg | 136,00 € | ||
500mg | 184,00 € |
Información del producto
- (2-dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl)(2'-amino-1 ,1'-biphenyl-2-yl)palladium(II) methanesulfonateMETHANESULFONATO(2-DICYCLOHEXYLPHOSPHINO-2' ,6'-DI-I-PROPOXY-1,1'-BIPHENYL)(2'-AMINO-1,1'-BIPHENYL-2-YL)PALLADIUM(II )
- RuPhos Palladacycle
RuPhos Pd G3 is a prodrug that is converted to RuPd G3 in vivo, its active form. It is an anti-cancer drug that inhibits the production of acetylcholine by binding to the muscarinic acetylcholine receptor. This leads to the inhibition of cancer cell growth and, ultimately, cancer cell death. RuPhos Pd G3 has been shown to be a slow-release drug with modulating effects on acetylcholine. The photostability of RuPhos Pd G3 has been demonstrated using fluorescent probes that bind to the acetylcholine receptor. The metabolic disorders associated with this drug are still unknown.
Propiedades químicas
Consulta técnica sobre: 3D-FR137452 RuPhos Pd G3
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.